跳到主要內容

臺灣博碩士論文加值系統

(18.97.14.80) 您好!臺灣時間:2024/12/12 19:31
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:郭明欣
研究生(外文):Kuo, Ming-shin
論文名稱:Cisapride速釋錠之配方探討
論文名稱(外文):A Study on the Formulation of Immediate Release Cisapride Tablet.
指導教授:詹道明詹道明引用關係
指導教授(外文):Thau-Ming Cham
學位類別:碩士
校院名稱:高雄醫學院
系所名稱:藥學研究所
學門:醫藥衛生學門
學類:藥學學類
論文種類:學術論文
論文出版年:1998
畢業學年度:86
語文別:中文
論文頁數:2
中文關鍵詞:溶解度市售品物性溶離全因子實驗設計法
外文關鍵詞:solubilityproperties of the general tabletdissolutionfull factorial design
相關次數:
  • 被引用被引用:0
  • 點閱點閱:417
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
本實驗分成三個部份進行。第一部份為探討介質之pH值,溫度及不同的媒
介對 Cisapride powder 之溶解度效應,並建立一個簡單,再現性佳之
HPLC方法及分析條件,以進行 Cisapride 溶液之檢測。第二部份為評估
三種具有衛生署認可生體相等性之市售 Cisapride 速效錠性質。探討項
目有物性檢測,包括崩散時間、硬度、脆度、厚度、直徑的測定,單一劑
量均一度試驗(重量差異性試驗、含量均一度試驗),溶離,及貯存之效
應等,以進一步了解市售品之間的品質差異性。第三部份為探討崩散劑、
崩散劑濃度及不同的賦形劑,對Cisapride自製錠物性(硬度、脆度、直
徑與厚度大小及崩散時間)及其溶離釋出之影響。並以23 full
factorial design實驗設計法配合ANOVA統計方法,分析上述三種變因對
Cisapride於2 min 時所釋出溶離百分率(%)之效應。另外,比較自製錠
與市售品之物性的差異性,並以SUPAC-IR溶離試驗比對軟體,比較自製錠
與三種市售品的溶離曲線差異性。由實驗結果發現,Cisapride powder
在0.1N HCl及pH4.5 acetate buffer中之溶解度很好,但完全不溶於
pH6.8 phosphate buffer中,添加界面活性劑可增加其溶解度,而以
sodium lauryl sulfate 之效果最好。於溫度的影響方面,Cisapride在
低pH值的介質時,受溫度的影響較在高pH值的介質大。以SUPAC-IR溶離試
驗比對軟體,比較三種市售品的溶離曲線差異性,結果發現兩種學名藥的
溶離曲線與原廠都不相似,?2值皆小於50。在四種溫度下貯存三個月後,
Cisapride powder的含量有減低的情形,尤其是貯存於60℃下,含量降低
的情形更為明顯。經過相同的條件貯存後,市售品品質的變化於高溫下較
低溫明顯。崩散劑臨界點濃度試驗結果顯示,Emcosoya 較Primojela 佳
。在Cisapride自製錠之物性試驗結果中觀察到,在硬度試驗方面,八個
處方的硬度範圍皆在6至7 kg之間。於脆度試驗方面,可以發現當崩散劑
以高濃度的Emcosoy混合製錠時,其脆性為最低。在直徑與厚度大小測定
方面,可觀察到當崩散劑濃度較高或使用lactose當作稀釋劑所製成的錠
劑時,厚度有較偏厚的情形。以崩散時間試驗方面,以崩散劑種類而言,
添加Emcosoy當作崩散劑,其崩散時間較添加Primojel短。以崩散劑濃度
而言,高濃度的崩散劑幫助錠劑於短時間崩散的效應較高,故崩散時間較
短。以稀釋劑種類以 lactose 與 Emcompress 作為賦形劑,Cisapride之
溶離速率慢且溶離率很差。經添加崩散劑後,溶離速率就明顯增加且溶離
率明顯增高,加入崩散劑的八個處方,不管最初的溶離速率如何,在 20
min 後其溶離率幾乎沒有差異。在實驗設計法分析結果顯示,崩散劑種類
、崩散劑濃度及賦形劑種類這三種變因對Cisapride 於2 min 之溶離率有
明顯的效應。但這三種變因之間並沒有明顯的交互作用。以SUPAC-IR溶離
試驗比對軟體,比較自製錠與三種市售品的溶離曲線差異性,其結果發現
市售品 A與以lactose當稀釋劑且不添加任何崩散劑的處方之溶離曲線相
似;市售品 B與處方5及處方6之溶離曲線相似;市售品 C與處方1、3、4
及7之溶離曲線相似。

The present study was carried out in three parts. Firstly, to
determine the solubility of cisapride powder in various pH value
of media at three different temperatures. The effects of various
surfactants on the solubility of the powder were also studied. A
reliable HPLC method for the determination of cisapride
concentration in solution was established.The evaluation on the
commercial products, cisapride tablets, was the second part. Two
generic tablets which were bioequivalent to the innovator's
product were studied for the general tablet properties, such as
disintegration time, hardness, friability, thickness, diameter,
uniformity of dosage units ( weight variation and content
uniformity ) and dissolution profile, then compared to those of
the innovator's product. The storage effects on these properties
were also determined.In the third part, the effects of various
disintegrants, disintegrant concentration and diluents on the
physical properties (disintegration time, hardness, friability,
thickness and diameter) and the release of cisapride tablet
were determined. A 23 full factorial design of experiments was
employed to evaluate the effects of the three factors on the
percentage release of cisapride;the subsequent data was
compared using analysis of variance ( ANOVA ). Furthermore, the
physical properties and dissolution pIt was found that cisapride
powder dissolved freely in 0.1N HCl and pH4.5 acetate buffer,
respectively but not in pH6.8 phosphate buffer. The solubility
of cisapride powder was increased by adding a surfactant to the
latter medium. Sodium lauryl sulfate was found to be the most
effective one. Temperature would have a greater influence on the
solubility of the cisapride powder for the lower pH medium.The
SUPAC-IR method showed that no similarity was found between the
innovator's product and the two respective generic products as
the ?2 values were smaller than 50.After storage for three
months at three different temperatures, the content of the
subsequent cisapride powder was decreased. The most serious
reduction was obtained at the highest temperature, 60℃. A
higher storage temperature also showed a more significant effect
on the properties of the commercial cisapride tablets.Both the
dissolution rate and amount release were poor for cisapride
tablets using either lactose or Emcompress per se as the
diluent. However, incorporation of a disintegrant in the tablet
formulation would markly increase the dissolution rate as well
as the percentage release of cisapride.The experimental design
study illustrated that the kinds of disintegrants, the
concentration of disintegrant and the kinds of diluents had
significant effects on the release percentage of cisapride
determined in two minutes, but had no significant interaction
between them.A cross-over comparison between the dissolution
profiles of the formulated cisapride tablets and the three
commercial products using the SUPAC-IR method produced some
informative results.

QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關期刊